TrialInflammatory bowel diseases2018

Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.

Aaron Yarlas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.